InvestorsHub Logo
Followers 2
Posts 251
Boards Moderated 0
Alias Born 05/29/2019

Re: None

Thursday, 09/12/2019 5:26:57 PM

Thursday, September 12, 2019 5:26:57 PM

Post# of 233357
Bruce Patterson, MD (incellDX, CEO) speaking at SH meeting was impressive. A very committed man with deep experience and insight with CCR5 expression. Really enthusiastic on Pro 140 as paradigm shift in Immuno-Oncology. Even more impressed in 20 minutes of listening to his enlightening discussion after meeting. Very articulate, and committed to ensuring next FDA meeting drives home CYDY has broad understanding and proof of mechanism for targeting and treatment via Pro-140 as CCR5 antagonist not just for HIV but in large range of I-O diseases.

And, he placed the first order for Pro-140: Income! Not much, but income, so ya! First customer!

Also, looking at IncellDX.com: Kindstar Global may be China connection? ref: https://incelldx.com/incelldx-content/uploads/Kindstar-Global-and-IncellDx-Press-Release.-08-05-2019.pdf

Disclaimer- I am just a guy with limited understanding. This thing still has multiple opportunities to go sideways- it is after all, just another little biotech start up.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News